What sector does Catalyst Pharmaceuticals Inc (CPRX) operate in?
Catalyst Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Catalyst Pharmaceuticals Inc (CPRX) current stock price?
As of the latest data, Catalyst Pharmaceuticals Inc stock price is $24.51, with a previous close of $23.60. Catalyst Pharmaceuticals Inc gained $0.91 in the last trading session, representing a 3.86% increase.
What is Catalyst Pharmaceuticals Inc (CPRX) current market capitalization?
Catalyst Pharmaceuticals Inc market cap is approximately 3.01 billion.
What is Catalyst Pharmaceuticals Inc (CPRX) Earnings Per Share (EPS)?
The trailing EPS is $1.71, and the forward EPS is $2.59.
What is Catalyst Pharmaceuticals Inc (CPRX) Price-to-Earnings (P/E) ratio?
Catalyst Pharmaceuticals Inc current P/E ratio is 14.33, with a forward P/E of 9.47.
What is Catalyst Pharmaceuticals Inc (CPRX) EBITDA?
Catalyst Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 80.45 million.
Does Catalyst Pharmaceuticals Inc (CPRX) pay dividends?
No. Catalyst Pharmaceuticals Inc does not pay a dividend.
How did Catalyst Pharmaceuticals Inc (CPRX) perform in its most recent earnings report?
In the last report (September 30, 2025), Catalyst Pharmaceuticals Inc posted an EPS surprise of 27.27% and a revenue surprise of 8.47%.
When is Catalyst Pharmaceuticals Inc (CPRX) next earnings report?
Catalyst Pharmaceuticals Inc is expected to release its next earnings report on December 31, 2025.
What is Catalyst Pharmaceuticals Inc (CPRX) beta (volatility) score?
Catalyst Pharmaceuticals Inc has a beta of 0.719, indicating lower volatility than the overall market.